Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1641 | 6423 | 47.7 | 81% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
588 | 12909 | HUNTINGTONS DISEASE//POLYGLUTAMINE//HUNTINGTIN |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
550 | 3241 | HUNTINGTIN//POLYGLUTAMINE//HUNTINGTONS DISEASE |
1918 | 2358 | HUNTINGTONS DISEASE//HUNTINGTON DISEASE//NEUROGENET RARE DIS |
18885 | 466 | 3 NITROPROPIONIC ACID//MITOCHONDRIAL TOXIN//3 NP |
21506 | 358 | INDIGOFERA SUFFRUTICOSA//2 NITROPROPANE//PROPANE 2 NITRONATE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HUNTINGTONS DISEASE | Author keyword | 1335 | 55% | 26% | 1692 |
2 | HUNTINGTIN | Author keyword | 374 | 73% | 4% | 282 |
3 | HUNTINGTON DISEASE | Author keyword | 312 | 61% | 5% | 331 |
4 | POLYGLUTAMINE | Author keyword | 261 | 56% | 5% | 316 |
5 | 3 NITROPROPIONIC ACID | Author keyword | 197 | 59% | 3% | 221 |
6 | ATAXIN 3 | Author keyword | 61 | 63% | 1% | 62 |
7 | NEUROGENET RARE DIS | Address | 56 | 100% | 0% | 19 |
8 | MOL MED THER EUT | Address | 47 | 24% | 3% | 172 |
9 | PREMANIFEST | Author keyword | 44 | 100% | 0% | 16 |
10 | MUTANT HUNTINGTIN | Author keyword | 42 | 83% | 0% | 24 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HUNTINGTONS DISEASE | 1335 | 55% | 26% | 1692 | Search HUNTINGTONS+DISEASE | Search HUNTINGTONS+DISEASE |
2 | HUNTINGTIN | 374 | 73% | 4% | 282 | Search HUNTINGTIN | Search HUNTINGTIN |
3 | HUNTINGTON DISEASE | 312 | 61% | 5% | 331 | Search HUNTINGTON+DISEASE | Search HUNTINGTON+DISEASE |
4 | POLYGLUTAMINE | 261 | 56% | 5% | 316 | Search POLYGLUTAMINE | Search POLYGLUTAMINE |
5 | 3 NITROPROPIONIC ACID | 197 | 59% | 3% | 221 | Search 3+NITROPROPIONIC+ACID | Search 3+NITROPROPIONIC+ACID |
6 | ATAXIN 3 | 61 | 63% | 1% | 62 | Search ATAXIN+3 | Search ATAXIN+3 |
7 | PREMANIFEST | 44 | 100% | 0% | 16 | Search PREMANIFEST | Search PREMANIFEST |
8 | MUTANT HUNTINGTIN | 42 | 83% | 0% | 24 | Search MUTANT+HUNTINGTIN | Search MUTANT+HUNTINGTIN |
9 | R6 1 | 42 | 94% | 0% | 15 | Search R6+1 | Search R6+1 |
10 | POLYGLUTAMINE DISEASE | 41 | 52% | 1% | 56 | Search POLYGLUTAMINE+DISEASE | Search POLYGLUTAMINE+DISEASE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MUTANT HUNTINGTIN | 1173 | 72% | 15% | 932 |
2 | NEURONAL INTRANUCLEAR INCLUSIONS | 744 | 71% | 9% | 595 |
3 | EXPANDED CAG REPEAT | 227 | 86% | 2% | 114 |
4 | PREDICT HD | 220 | 93% | 1% | 82 |
5 | INTRANUCLEAR INCLUSIONS | 220 | 49% | 5% | 327 |
6 | WILD TYPE HUNTINGTIN | 215 | 96% | 1% | 68 |
7 | NEUROLOGICAL PHENOTYPE | 189 | 88% | 1% | 91 |
8 | GLUTAMINE REPEATS | 176 | 62% | 3% | 180 |
9 | EXPANDED POLYGLUTAMINE | 174 | 53% | 4% | 232 |
10 | BASAL GANGLIA VOLUME | 146 | 88% | 1% | 68 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Huntington's disease: from molecular pathogenesis to clinical treatment | 2011 | 286 | 152 | 82% |
Autophagy in Huntington disease and huntingtin in autophagy | 2015 | 9 | 102 | 39% |
Huntington's disease | 2007 | 521 | 109 | 83% |
Transcription, Epigenetics and Ameliorative Strategies in Huntington's Disease: a Genome-Wide Perspective | 2015 | 4 | 189 | 65% |
Huntington disease: natural history, biomarkers and prospects for therapeutics | 2014 | 21 | 125 | 94% |
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease | 2010 | 238 | 641 | 72% |
Choosing an animal model for the study of Huntington's disease | 2013 | 36 | 185 | 83% |
Mechanisms of neurodegeneration in Huntington's disease | 2008 | 177 | 261 | 83% |
Huntington's Disease: Can Mice Lead the Way to Treatment? | 2011 | 73 | 134 | 85% |
Huntington's disease: a clinical review | 2010 | 81 | 24 | 96% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUROGENET RARE DIS | 56 | 100% | 0.3% | 19 |
2 | MOL MED THER EUT | 47 | 24% | 2.7% | 172 |
3 | HUNTINGTON NRW | 27 | 71% | 0.3% | 22 |
4 | HUNTINGTONS DIS CLIN | 21 | 85% | 0.2% | 11 |
5 | NEUROIMAGING AGING NEURODEGENERAT DIS | 20 | 100% | 0.1% | 9 |
6 | TRANSLAT NEUROENDOCRINE UNIT | 17 | 62% | 0.3% | 18 |
7 | STRUCT NEUROPATHOL | 15 | 31% | 0.6% | 39 |
8 | HUNTINGTONS DIS PROGRAM | 15 | 88% | 0.1% | 7 |
9 | TAUBE KORET HUNTINGTONS DIS | 13 | 62% | 0.2% | 13 |
10 | HUNTINGTONS DIS FORUM | 11 | 100% | 0.1% | 6 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000033333 | HEREDITARY SPASTIC PARAPLEGIA//FRIEDREICHS ATAXIA//FRIEDREICH ATAXIA |
2 | 0.0000010365 | INDOLEAMINE 2 3 DIOXYGENASE//KYNURENIC ACID//KYNURENINE |
3 | 0.0000009427 | AMYOTROPHIC LATERAL SCLEROSIS//SPINAL MUSCULAR ATROPHY//MOTOR NEURON DISEASE |
4 | 0.0000009246 | RKIP//RAF KINASE INHIBITOR PROTEIN//HIPPOCAMPAL CHOLINERGIC NEUROSTIMULATING PEPTIDE |
5 | 0.0000009012 | GENETIC TESTING//JOURNAL OF GENETIC COUNSELING//GENETIC COUNSELING |
6 | 0.0000007721 | ALPHA SYNUCLEIN//PARKIN//LRRK2 |
7 | 0.0000006699 | AUTOPHAGY//BECLIN 1//LC3 |
8 | 0.0000005313 | PROTEASOME//UBIQUITIN//NEDD8 |
9 | 0.0000004949 | ALZHEIMERS DISEASE//AMYLOID PRECURSOR PROTEIN//BETA AMYLOID |
10 | 0.0000004415 | UNFOLDED PROTEIN RESPONSE//ENDOPLASMIC RETICULUM STRESS//ER STRESS |